These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19893058)

  • 1. Atherosclerosis and lupus: what we know and what we should know.
    Doria A
    J Rheumatol; 2009 Nov; 36(11):2380-2. PubMed ID: 19893058
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
    Serikova SIu; Kozlovskaia NL; Shilov EM
    Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk assessment and treatment in systemic lupus erythematosus.
    Elliott JR; Manzi S
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):481-94. PubMed ID: 19591779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premature atherosclerotic cardiovascular disease and systemic lupus erythematosus from bedside to bench.
    Von Feldt JM
    Bull NYU Hosp Jt Dis; 2008; 66(3):184-7. PubMed ID: 18937629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premature atherosclerosis-related central nervous system involvement in two cases of systemic lupus erythematosus.
    Zhang X; Tian X; Zhang F
    J Clin Rheumatol; 2007 Aug; 13(4):211-2. PubMed ID: 17762456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.
    Kiss E; Soltesz P; Der H; Kocsis Z; Tarr T; Bhattoa H; Shoenfeld Y; Szegedi G
    J Autoimmun; 2006 Dec; 27(4):211-7. PubMed ID: 17088047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated atherosclerosis in patients with systemic autoimmune diseases.
    de Leeuw K; Kallenberg C; Bijl M
    Ann N Y Acad Sci; 2005 Jun; 1051():362-71. PubMed ID: 16126978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
    Zampieri S; Iaccarino L; Ghirardello A; Tarricone E; Arienti S; Sarzi-Puttini P; Gambari P; Doria A
    Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke subtypes among young patients with systemic lupus erythematosus.
    Krishnan E
    Am J Med; 2005 Dec; 118(12):1415. PubMed ID: 16378793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus.
    de Leeuw K; Graaff R; de Vries R; Dullaart RP; Smit AJ; Kallenberg CG; Bijl M
    Rheumatology (Oxford); 2007 Oct; 46(10):1551-6. PubMed ID: 17848401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical atherosclerosis in systemic lupus erythematosus.
    Ahmad Y; Bruce IN
    J Rheumatol; 2004 May; 31(5):841-3. PubMed ID: 15124239
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of inflammatory cytokines in the pathogenesis of systemic lupus erythematosus-related atherosclerosis: a novel target for treatment?
    Shovman O; Gilburd B; Shoenfeld Y
    J Rheumatol; 2006 Mar; 33(3):445-7. PubMed ID: 16511912
    [No Abstract]   [Full Text] [Related]  

  • 15. Damage, accelerated atherosclerosis, and mortality in patients with systemic lupus erythematosus: lessons from LUMINA, a multiethnic US cohort.
    Durán S; González LA; Alarcón GS
    J Clin Rheumatol; 2007 Dec; 13(6):350-3. PubMed ID: 18176147
    [No Abstract]   [Full Text] [Related]  

  • 16. Atherosclerosis and central nervous system involvement in systemic lupus erythematosus.
    Von Feldt JM
    J Clin Rheumatol; 2007 Aug; 13(4):179-80. PubMed ID: 17762449
    [No Abstract]   [Full Text] [Related]  

  • 17. Subclinical atherosclerosis in systemic lupus erythematosus.
    Mercado U; Avendaño L
    J Rheumatol; 2005 Jun; 32(6):1171-2; author reply 1172-3. PubMed ID: 15940743
    [No Abstract]   [Full Text] [Related]  

  • 18. Should all patients with systemic lupus erythematosus receive cardioprotection with statins?
    Toloza S; Urowitz MB; Gladman DD
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):536-7. PubMed ID: 17700557
    [No Abstract]   [Full Text] [Related]  

  • 19. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
    Haque S; Mirjafari H; Bruce IN
    Curr Opin Lipidol; 2008 Aug; 19(4):338-43. PubMed ID: 18607179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerotic cardiovascular disease in systemic lupus erythematosus: the Beer Sheva experience.
    Abu-Shakra M; Codish S; Zeller L; Wolak T; Sukenik S
    Isr Med Assoc J; 2008 Jan; 10(1):43-4. PubMed ID: 18300571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.